Introduction {#S1}
============

The World Health Organization recommends breast milk as the ideal food source for growth and development of infants ([@B1]). Human milk functions not only as food for the infant, but also protects against infection, promotes intestinal, immune, and cognitive development ([@B2]), and stimulates establishment of the unique gut microbiome ([@B3], [@B4]) of the breastfed infant. Breastfeeding also has beneficial effects on short- and long-term maternal and infant health outcomes. Teens and adults who were breastfed as babies are less likely to be overweight or obese and less likely to develop type-2 diabetes as well as perform better on intelligence tests ([@B4]). Mothers who breastfeed return to their pre-pregnancy weight faster, have lower rates of obesity, and lower risks of developing breast and ovarian cancers ([@B1]).

Due to the tremendous health benefits of breastfeeding, the American Academy of Pediatrics recommends exclusive breastfeeding (i.e., no supplementation with formula or solid food) for about 6 months, with continuation of breastfeeding for 1 year or longer as mutually desired by mother and infant ([@B5]). Economic analysis of breastfeeding benefits revealed that \$13 billion in healthcare costs would be saved and 911 infant deaths prevented each year if 90% of families in the US complied with medical recommendations to breastfeed exclusively for 6 months ([@B6]). However, rates of adequate breastfeeding are far below national targets. The 2011 National Immunization Survey reported rates of breastfeeding initiation were at 79.2%, with breastfeeding rates dropping precipitously after that. Exclusive breastfeeding fell by 20%, to 59% at 1 week post-partum, 40.7% at 3 months, and only 18.8% of mothers exclusively breastfed for 6 months ([@B7]).

The most common reason mothers cite for stopping breastfeeding before their infant reached 2 weeks old, was that the baby was unsettled, a behavior often interpreted by mothers as indicating an insufficient milk supply ([@B8]). Delayed lactogenesis II (DLII), the onset of milk "coming in" more than 72 h post-partum, is a major contributor to early formula supplementation, inadequate breastfeeding, and breastfeeding cessation ([@B9], [@B10]). Further, infants of mothers who experience DLII are seven times more likely to lose excessive weight the first 5 days after birth ([@B11]).

Lactogenesis in Women {#S2}
=====================

Lactogenesis occurs in several stages. Lactogenesis I occurs during pregnancy and is the initiation of the synthetic capacity of the mammary glands. Lactogenesis II commences after delivery and is the initiation of plentiful milk secretion. Changes in milk composition from colostrum to mature milk in combination with a sudden feeling of breast fullness mark the onset of lactogenesis II, which normally occurs between 30 and 40 h following the birth of a full-term infant ([@B10]). Lactogenesis II is initiated post-partum by a fall in progesterone while prolactin levels remain high. The process does not depend on suckling of the infant until about the third or fourth day post-partum. Comparison between breastfeeding and non-breastfeeding women showed prolactin levels and milk secretion volumes are the same between groups of women the first 2 days post-partum ([@B12], [@B13]). Beginning day 3, post-partum prolactin levels begin to become significantly less in non-lactating women ([@B12]), and by day 4, secretion volume is lower in non-lactating women with lack of milk-removal initiating mammary involution and compositional differences in breast secretions between the groups ([@B13]). Thus, although breastfeeding is not necessary for initiation of lactogenesis II, it is essential for the continuation of lactation. The final stage of lactogenesis, lactogenesis III, also called galactopoiesis, is the production and maintenance of mature milk from day 9 post-partum, until weaning.

Risk Factors for Delayed Onset of Lactogenesis II {#S3}
=================================================

Risk factors associated with DLII include primiparity, Cesarean delivery, longer duration of labor, and elevated blood cortisol concentrations (Table [1](#T1){ref-type="table"}). The risk for low milk volume on day 4 post-partum was 4.3-fold (95% confidence interval-CI: 1.5--12.4) higher for mothers of pre-term infants delivered by Cesarean section versus vaginally ([@B14]). In this study, Cesarean delivery was associated with pregnancy-induced hypertension, delayed milk expression initiation, and low pumping frequency. Together, these findings suggest a composite of underlying risk factors contributes to the association of Cesarean delivery with DLII and low milk volume.

###### 

**Risk factors for delayed or failed lactogenesis II \[Modified from Ref. ([@B10])\]**.

  ---------------------------------------------------
  **Delayed lactogenesis II**
  Primiparity
  Psychosocial stress/pain
  Maternal obesity
  Diabetes
  Hypertension
  Stressful labor and delivery
  Cesarean section
  Delayed first breastfeed episode
  Low perinatal breastfeeding frequency
  Elevated cortisol
  **Failed lactogenesis II and/or low milk supply**
  Breast surgery/injury
  Retained placental fragments
  Cigarette smoking
  Hypothyroidism, hypopituitarism
  Ovarian theca-lutein cyst
  Insufficient mammary glandular tissue
  Polycystic ovarian syndrome
  ---------------------------------------------------

Studies of primiparous women revealed that independent risk factors for DLII were maternal age ≥30 years, body mass index (BMI) in the overweight or obese range, and infant birth weight \>3600 g ([@B15]). A dose-response relation to BMI was evident, with risk of DLII being 1.84 (95% CI: 1.02--2.80) times higher in overweight and 2.21 (95% CI: 1.52--4.30) times higher in obese women, as compared with women with a BMI in the healthy range ([@B15]). In obese women, DLII was not associated with psychosocial factors, such as planned duration of breastfeeding or behavioral beliefs about breast- and bottle-feeding ([@B16]). Therefore, it is likely that there is a physiological basis for the delay. Older maternal age and higher BMI are known risk factors for gestational diabetes ([@B17]). Lower glucose tolerance in the antenatal period was associated with longer time to onset of lactation ([@B18]), and prolactin release in response to suckling in the early post-partum period was found to be significantly lower in the overweight/obese women compared to healthy weight women ([@B19]). Importantly, low prolactin levels in women, as described for Sheehan's syndrome, are associated with failed lactogenesis II ([@B20]). In addition, DLII often leads to failed lactogenesis II ([@B14]). Failed lactogenesis II is a condition wherein the mother is either able to achieve full lactation but an extrinsic factor has interfered with the process, or one or more factors results in failure to attain adequate milk production ([@B10]). Failed lactogenesis II can be described further in the context of two types of conditions: a primary inability to produce adequate milk volume, or a secondary condition as a result of improper breastfeeding management and/or infant-related problems ([@B10]).

Metabolic-Hormonal Adaptations to Lactation {#S4}
===========================================

Lactation is the continuum of reproduction in mammals, and the most energetically demanding stage. Metabolically, the reproductive process in females can be divided into three periods which correspond to the energetic needs of the fetus and neonate. Period one spans the first two-thirds of pregnancy. There is little demand for nutrients by fetus during the first two trimesters, so the mother uses this time to store energy by increased consumption and enhanced lipogenesis ([@B21]). To support large gains in fetal growth, the mother transitions to a catabolic state in the last third of pregnancy, period two. Period two is characterized by increased gluconeogenesis, decreased peripheral tissue glucose utilization, increased fatty acid mobilization from adipose, and increased amino acid mobilization from muscle ([@B22]). Period three is lactation. During this period, the dam's metabolism changes to accommodate the even greater energetic demands of milk synthesis. All the lactose and protein and most lipids in milk are synthesized in mammary gland, and thus the mammary gland has a high requirement for circulating substrates (glucose, amino acids, free fatty acids, and triglycerides) ([@B21]--[@B23]). In addition to further increasing metabolic responses described for period 2, there are substantial increases in size and complexity of the maternal intestine, liver, and cardiovascular system, including increased mammary blood flow, increased blood flow to liver and gastrointestinal tract, and higher cardiac output ([@B24]). Thus, the transition from pregnancy to lactation represents a major physiological change requiring on the one hand, coordinated changes in various body tissues, and on the other hand, mammary-specific changes to support a dominant physiological process (production of milk).

During pregnancy and at the onset of lactation, dramatic changes in circulating levels of reproductive and metabolic hormones (e.g., estrogen, progesterone, placental lactogen, prolactin, leptin, and cortisol) occur ([@B12], [@B25]). Hormonal changes stimulate metabolic changes in almost every organ of the body so that nutrients and energy can be diverted to the fetus to support growth before birth and then to the mammary gland to support milk synthesis post-partum ([@B26], [@B27]). Therefore, factors affecting metabolic-hormonal regulation (e.g., obesity, diabetes, hypothyroidism) during pregnancy, may also impact the ability of the mother to initiate lactation.

During pregnancy, the high levels of circulating progesterone enable differentiation of the mammary gland while inhibiting the secretory process of the mammary gland. Once the placenta is expelled after birth, progesterone levels decline rapidly, and increasing prolactin levels trigger the beginning of lactogenesis II ([@B28]). Neonatal suckling induces a neuroendocrine response that stimulates secretion of prolactin and glucocorticoids as well as oxytocin, which stimulates expulsion of milk from the gland ([@B29]). Increases in prolactin, estradiol, and cortisol levels during the periparturient period decrease peripheral tissue insulin sensitivity and responsiveness. These changes in insulin homeostasis result in increased rates of lipolysis and gluconeogenesis and decreased rates of glucose uptake by adipose and muscle, and decreased protein synthesis in muscle with concomitant increases in protein degradation and amino acid release ([@B23], [@B30]). Thyroid hormones are also essential for efficient milk production ([@B31]). A study of women with insufficient lactation found that the nasal administration of thyrotropin-releasing factor increased prolactin and daily milk volume ([@B32]).

Hypothesis: Metabolic--Hormonal--Circadian Clock Link to Delayed Lactogenesis II {#S5}
================================================================================

As outlined above, maternal hormonal milieu stimulates metabolic adaptations to reproductive state and mammary gland responsiveness. Therefore, it follows that conditions with a hormonal etiology (e.g., diabetes, hypothyroidism, or obesity) may interfere with these adaptations and cause a delay in lactogenesis II ([@B10]). Furthermore, some delivery modes and conditions that result in a delay in breastfeeding initiation and/or breast stimulation (e.g., pre-term, Cesarean, or a prolonged second stage of labor) may impact periparturient hormonal milieu needed to stimulate metabolic and mammary-specific adaptations needed to initiate copious milk secretion. We hypothesize that disruption of the circadian timing system during pregnancy and peripartum play a role in DLII.

The circadian timing system is intimately linked and reciprocally regulated by hormones and metabolism, and below we describe our preliminary studies that support this hypothesis. In addition, we summarize findings from a comprehensive database search in PubMed used to further support our hypothesis. In searching the literature to investigate this hypothesis, we found one of the immediate challenges encountered was the lack of studies conducted relating to the circadian timing system in pregnant or lactating women ([@B33]--[@B36]). In addition, information about what was considered normal or abnormal for circadian rhythms in pregnancy and lactation was lacking. Thus, much of the evidence used to develop and support our hypothesis was drawn from studies conducted on a more general population or inferred from animal studies.

The Circadian Timing System {#S6}
===========================

Nearly all physiological and behavioral functions of animals are rhythmic including secretion patterns of hormones, sleep--wake cycles, metabolism, and core body temperature. These circadian rhythms, 24 h cycles in biochemical, physiological, or behavioral processes, evolved as a common strategy among animals to coordinate internal systems and synchronize these systems to the environment ([@B37], [@B38]). Circadian rhythms are generated at the molecular level by circadian clocks. In mammals, circadian clocks are regulated hierarchically, with the master circadian clock located centrally in the suprachiasmatic nuclei (SCN) of the hypothalamus. In addition to the SCN, there are peripheral clocks distributed in every organ. The intrinsic rhythmicity of the SCN is entrained by synchronization to the 24-h day to regularly occurring environmental signals. The light--dark cycle is the most important environmental cue for entraining the master clock ([@B39]). Other cues include exercise, food availability, temperature, and stress, which directly or indirectly entrain the SCN ([@B40], [@B41]). The SCN integrates this temporal information and translates it into hormonal and autonomic signals that influence and synchronize peripheral clocks in every tissue of the body ([@B42]). In turn, peripheral clocks drive the circadian expression of local transcriptomes, thereby coordinating metabolism and physiology of the entire animal.

The circadian timing system must continuously adapt to and synchronize with the environment and the body's internal signals in order to organize clocks into a coherent functional network that regulates behavior and physiology. Hallmarks of organization of circadian timing are the perception of environmental input, integration of time-related information into the circadian clock "device" (molecular clock), and transmission of adjusted timing information as output of metabolic and physiological processes (Figure [1](#F1){ref-type="fig"}). The molecular clock mechanism is based on a transcription-translation feedback loop. At the core of this loop are two transcription factors, CLOCK (or its ortholog NPAS2) and BMAL1, which in the form of a heterodimer drive rhythmic expression of output genes either directly via E-box regulatory element in their promoter regions, or indirectly by other transcription factors whose expression is under clock control ([@B43]). Among transcriptional targets of this complex are *Period* and *Cryptochrome* genes, whose products function as negative regulators of CLOCK/BMAL1-mediated transcription \[Figure [1](#F1){ref-type="fig"}; ([@B44])\]. Approximately, 10--20% of genes expressed in a tissue exhibit circadian rhythms ([@B45]). Tissue-specific clock-controlled genes are involved in rate-limiting steps critical for organ function. For example, in the liver, molecules involved in metabolism of carbohydrate, lipid, and cholesterol encode genes that exhibit coordinated circadian expression ([@B45]). We propose that the mammary clock functions to regulate gland development and metabolic output \[Figure [1](#F1){ref-type="fig"}; ([@B46])\].

![**Hallmarks of organization of clocks and circadian timing system**. **(A)** Illustration of primary input (light) to the SCN and outputs that include regulation of hormones (e.g., prolactin and cortisol) and metabolism. **(B)** Illustration of the transcription-translation feedback loop of the core molecular clock device, with proposed inputs \[prolactin (PRL) and cortisol\] and outputs (regulation of breast development and milk production) of mammary clock. At the core of the transcription-translation feedback loop are two transcription factors, CLOCK (or its ortholog NPAS2) and BMAL1, which in the form of a heterodimer drive rhythmic expression of output genes either directly via E-box regulatory element in their promoter regions, or indirectly by other transcription factors whose expression is under clock control ([@B43]). Among transcriptional targets of this complex are *Period* and *Cryptochrome* genes, whose products function as negative regulators of CLOCK/BMAL1-mediated transcription.](fnut-02-00004-g001){#F1}

Intimate interactions and reciprocal regulation occur between metabolic and circadian systems. The endogenous circadian timing system coordinates daily patterns of feeding, energy utilization, and energy storage across the daily 24 h cycle ([@B47]). Many metabolic hormones exhibit circadian rhythms. For example, cortisol levels are highest in the early morning and lowest at the first part of the biological night ([@B47]). Further, the SCN is responsible for a 24-h rhythm in plasma glucose concentrations, with the highest concentrations occurring toward the beginning of the activity period ([@B48]).

Chronodisruption: Consequences to Metabolism and Health {#S7}
=======================================================

Disruptions of normal circadian timing can evoke a multitude of downstream effects, including reorganizing the entire physiological state. Depressive mood ([@B41]), light, activity, and eating at night \[e.g., night-shift work and night-eating syndrome; ([@B49]--[@B53])\], excessive weight ([@B54]), stress, and sleep disturbances ([@B55]) have all been characterized as chronodisruptors, i.e., factors that disrupt circadian rhythms. Circadian disruption can result in disorders such as diabetes, obesity, and cardiac disease ([@B56]--[@B58]). In humans, living in modern industrialized societies with 24 h access to light coupled with work and social obligations often leads to behaviors that are inappropriately timed relative to endogenous circadian rhythms. Night-shift work is an example of severe circadian disruption, as workers are awake, active, and eating during their biological night and trying to sleep and fast during their biological day ([@B59]).

Animal studies demonstrated that being active and feeding during the usual rest phase leads to alterations in metabolism and weight gain, even with the same caloric intake ([@B60]). In humans, internal desynchronization can be induced by a forced 28-h sleep--wake cycle (8 h sleep, 20 h awake), which is outside the range of entrainment for the human circadian clock ([@B61]). After four cycles, this protocol results in circadian misalignment, in which the behavioral sleep--wake cycle is 12 h out of phase with the circadian cycle. In these misaligned conditions, leptin rhythms are blunted, postprandial glucose and insulin are increased, and cortisol rhythms are 180° out of phase with the behavioral rhythm. Nearly half of the participants undergoing the 28-h cycle exhibited a pre-diabetic state during circadian misalignment ([@B62]).

Epidemiological studies have shown night-shift work, which disrupts the circadian system, is associated with development of obesity. Studies of women with phase-delayed eating patterns, such as not eating breakfast or night-eating syndrome, are associated with increased BMI, altered metabolism, changes in plasma hormone concentrations and rhythms, and depressive mood ([@B52], [@B53]). At the molecular level in humans, a single nucleotide polymorphism in CLOCK is associated with abnormal fatty acid metabolism and development of fatty liver, and a polymorphism in the BMAL1 core circadian clock gene is associated with susceptibility to hypertension and type-2 diabetes ([@B63], [@B64]).

In reciprocal, the over-fat state is characterized by alterations of circadian rhythms. In obese mice, there is attenuation of rhythmic gene expression patterns ([@B65]), and a delay in circadian entrainment to light-phase shift ([@B66]). Circadian rhythms of glucose and insulin are elevated in obese rats throughout the 24-h period. Levels of growth hormone, prolactin, and thyroxine are depressed. Serum levels of corticosterone do not exhibit distinct circadian rhythms and are elevated throughout the circadian cycle in obese rats ([@B67]). Similarly, in obese humans, basal levels of cortisol are higher with an attenuation of the circadian rhythm ([@B68]) and a lengthening of rhythm period ([@B54]).

With the advent of electric lighting, humans in industrialized societies are exposed to light at night. The natural light--dark cycle is the most salient cue for entraining the master clock to the 24-h day. The SCN communicates photoperiodic information to the pineal gland, where light inhibits melatonin secretion, such that melatonin secretion normally occurs at night. Melatonin has a fundamental role in regulating and timing several physiological functions, including glucose homeostasis, insulin secretion, and energy metabolism ([@B69]). As such, metabolism is impaired after a reduction in melatonin production, and the basic processes associated with acquisition and utilization of energy are functionally altered after exposure to extended periods of artificial lighting ([@B70]). Chronic light at night exposure suppresses melatonin levels as well as disrupts central clock rhythms, both of which are implicated in metabolic disturbances that predispose individuals to the development of type-2 diabetes, obesity, and metabolic syndrome ([@B70]). For example, a recent cross-sectional study of 500 people in Japan ([@B71]) found that elderly people sleeping in lighter rooms had higher body weight, waist circumference, and BMI; in that study, light exposure and obesity outcome variables were all objectively measured, although the BMI of participants was generally low (an average of 22.8). A large cohort study of 100,000 women revealed that the association between light at night exposure and obesity increased the odds of obesity with increasing levels of light at night exposure ([@B72]).

Sleep is cooperatively regulated by homeostatic and circadian factors. Voluntary sleep curtailment has become common in many modern life styles. For example, although the National Institutes of Health recommends that adults need 7--8 h of sleep per day ([@B73]), data from the National Health Interview Survey, found nearly 30% of adults reported an average of ≤6 h of sleep per day in 2005--2007 ([@B74]). Less than 1 week of sleep curtailment in healthy young men was associated with lower glucose tolerance, lower thyrotropin concentrations, and raised evening concentrations of cortisol ([@B75]). Poor sleep quality is also associated with increased risk for depression ([@B76]). Whereas short sleep duration is associated with increased incidence of diabetes, obesity ([@B77]), as well as increased all-cause mortality ([@B78]), there also appears to be a consistent association of poor sleep quality and short sleep duration with increased risk of cardiovascular disease, an association that is stronger in women than men ([@B79], [@B80]).

Disrupted sleep includes both abnormal sleep patterns and sleep deprivation. Studies have shown that disrupted sleep cycles impair the function of adipocytes, which regulate leptin levels ([@B81]). Abnormal leptin levels may lead to irregular meal times ([@B82]). This disrupts the balance between insulin and glucose cycles, causing reductions in insulin sensitivity and increases in glucose concentration, a prelude to diabetes ([@B47], [@B81], [@B83]). Lipid metabolism is similarly impaired, which may lead to increased lipogenesis, and by extension, obesity ([@B82], [@B83]). Impaired carbohydrate and lipid metabolism from disrupted circadian rhythms have also been linked to increased risk of cardiovascular disease ([@B83], [@B84]).

In human studies of shift work and atypical schedules, irregular sleep and disruptive circadian rhythms appear together, indicating that the two are closely related and that the presence of one usually entails the other ([@B85], [@B86]). In humans, sleep is normally timed to occur during the biological night, when body temperature is low and melatonin is synthesized. The sleep--wake cycle, and associated cycles of darkness and light and fasting and feeding, interacts with the circadian system and is a major driving factor of rhythms in physiology and behavior ([@B87]). Desynchrony of sleep-wake timing and other circadian rhythms, such as occurs in shift work and jet-lag, is associated with disruption of rhythmicity in physiology and endocrinology ([@B87]). Insufficient or mistimed sleep reduces the rhythmicity of clock-controlled transcripts and expression of core circadian clock genes. Thus, circadian disruption occurs as a result of irregular sleep patterns, ([@B47], [@B82], [@B85], [@B86]), and in converse circadian abnormalities can also result in sleep disturbances ([@B88]).

In summary, changes in glucose and lipid metabolism, abnormally high levels of cortisol at night, changes in melatonin, leptin, and thyroid hormone levels, as well as cardiovascular problems and development of type-2 diabetes are commonly associated with disruptions in circadian rhythms. Exposure to light, activity or eating at night, sleep disturbances/curtailment, depression, and stress are common chronodisruptors in many modern life styles and work schedules, and thus may be partly responsible for the rise in metabolic disease and obesity apparent in many industrialized societies ([@B89]).

Circadian System Regulation of and Adaptations to Pregnancy and Lactation {#S8}
=========================================================================

As highlighted in multiple recent review articles ([@B33], [@B90]--[@B92]), much more work is needed to understand interactions among circadian clocks, metabolism, and female reproductive cycles and states. What is known, is that the circadian system plays a key role in the timing of reproductive events and hormones important to the regulation of pregnancy and lactation. For example, neural mechanisms regulating ovulation are under circadian control in many species to ensure that the timing of greatest fertility coincides with the period of maximal sexual motivation ([@B93]). SCN lesions result in infertility in rodents, due to the lack of the ability to synchronize events for ovulation ([@B94]), and mice with mutant core clock genes or core clock-gene knocked-out mice exhibit reduced fertility and fecundity ([@B95], [@B96]).

The SCN has been shown to be necessary for normal functioning of the hypothalamic-pituitary-gonadal (HPG) axis, and rhythms of clock-gene expression have been recorded in brain regions controlling both the HPG and hypothalamic-pituitary-adrenal (HPA) axis ([@B97]). Rhythmic gene expression of prolactin in pituitary mammotrophs was shown to be mediated by CLOCK--BMAL1 binding to clock-gene regulatory elements ([@B98]). In addition, ovariectomized and estradiol-treated rats fail to exhibit a prolactin surge following SCN lesions. Furthermore, SCN lesion also prevents the twice daily prolactin surge induced by mating in rodents, which maintains the corpus luteum and thus the secretion of progesterone and pregnancy maintenance \[for review, see Ref. ([@B93])\], suggesting the central clock plays a direct or indirect role in regulation of prolactin secretion. Therefore, it is interesting to speculate that decreased blood prolactin observed in healthy, young non-pregnant women following exposure to partial sleep deprivation ([@B99]) is due to the disruption of the master clock.

Circadian rhythms in behavior and physiology change substantially as female mammals transition through the reproductive states of non-pregnancy, pregnancy, and lactation, with changes in circadian rhythms supporting physiological demands unique to each of these stages ([@B100]--[@B104]). For example, to compensate for increases in the daily temperature minimum during gestation studies of pregnant laboratory animals showed phase of body temperature rhythm was advanced and amplitude decreased relative to non-pregnant controls ([@B100]). Further, to compensate for the increased need for sleep in early pregnancy, sleep patterns are altered in pregnant rodents ([@B103], [@B105]).

Sleep is also significantly impacted by pregnancy in women. A study of 192 pregnant women surveyed retrospectively found 88% had alterations in sleep compared with their usual experience ([@B106]). Reported changes included insomnia, parasomnias (nightmares and night terrors), restless leg syndrome, snoring, and sleep apnea. Among the most frequent self-reported causes of sleep disturbance during pregnancy were urinary frequency, back or hip ache, and heartburn. A prospective, cohort study of healthy nulliparous women found compared with the baseline assessment done before 20 weeks gestation, mean sleep duration in the third trimester was significantly shorter (7.4 h compared with 7.0 h), and overall poor sleep quality became significantly more common as pregnancy progressed ([@B107]). Okun and Coussons-Read collected qualitative sleep data at 12, 24, and 36 weeks' gestation, and found as early as 12 weeks, pregnant women reported an increased number of naps, nocturnal awakenings, time spent awake during the night, and poorer sleep quality than non-pregnant women ([@B108]).

The dramatic fluctuations in reproductive hormones that occur during pregnancy and the transition from pregnancy to the post-partum period are accompanied by alterations in circadian rhythms of melatonin ([@B109], [@B110]) and cortisol ([@B111]). In seasonally breeding animals, melatonin regulates reproductive hormones and behavior ([@B112]). During pregnancy in humans, night time melatonin levels increase linearly with progressive weeks of gestation, and fall in the early post-partum period ([@B110]). Changes in cortisol dynamics during pregnancy are due in part to the remodeling of maternal HPA axis, which results in an altered maternal stress response and energy balance, as well as rising placental cortico-releasing hormone (CRH) levels ([@B113]). Change in the HPA axis and placental CRH result in attenuated rhythms of plasma cortisol and a period of hypercortisolism beginning in mid-gestation. Following birth of the neonate, maternal plasma levels of cortisol drop due to loss of placental CRH, if the mother breastfeeds, attenuation in cortisol rhythms and stress response continue throughout lactation ([@B114], [@B115]). Synchronization among the multitude of molecular clocks in the body is believed to be regulated in part by cortisol circadian rhythms which are regulated by the central clock ([@B116]). Thus, changes in cortisol secretion patterns during pregnancy and lactation have the potential to affect circadian rhythms across the entire body.

Timing of parturition in women also shows signs of being regulated by the circadian timing system. For example, the onset of labor and spontaneous membrane rupture peaks at night between midnight and 4:00 a.m. ([@B117]--[@B119]), and the timing of births peak around 1:00--2:00 p.m. for primiparous women ([@B120]). Further, a nested, randomized, controlled clinical trial that compared morning versus evening administration of prostaglandin and its success rate in inducing labor, reported no difference in rate of Cesarean delivery, however morning inductions required less oxytocin, had a shorter induction to birth interval, and were less likely to result in instrumental vaginal births for primiparous mothers ([@B121]).

During lactation in women, the potent lactogens, prolactin and cortisol, exhibit circadian variation in secretion. The prolactin-secretory response to nursing is superimposed on the endogenous circadian rhythm of prolactin secretion, thus the suckling stimulus elevates prolactin levels more effectively at certain times of day when the circadian input enhances the suckling stimulus-evoked secretory response ([@B122]). Studies in lactating rabbits revealed timing the single bout of daily suckling that occurs in this species shifted PER1 expression in SCN clock and in peripheral clocks of the brain ([@B76], [@B77]). Our *in vitro* studies showed prolactin and glucocorticoids can directly affect mammary clock, with prolactin inducing phase shifts in core clock genes expression, suggesting that external cues emanating from neonate can have effects on maternal circadian physiology.

Our rodent studies also demonstrated that during the transition from pregnancy to lactation, dynamic changes in core clocks occurred in multiple tissues. The amplitude of core clock genes' expression increased significantly in the SCN and liver ([@B123]). Work of others found that expression of PER2 expression shifted and amplitude increased in SCN in early pregnant versus diestrus rats ([@B124]). The central clock functions to synchronize the timing of metabolic and reproductive functions, and thus changes in the SCN during the transition in physiological states may function to mediate coordinated changes in tissue-specific metabolism needed to support pregnancy and lactation. Increases in amplitude of hepatic expression of core clock genes' rhythms during the transition from pregnancy to lactation, likely reflect the increase in liver metabolic output ([@B123]). In addition, changes revealed in mammary clock dynamics led us to hypothesize that differentiation-driven changes during the transition from pregnancy to lactation in the mammary clock are stimulated, in part, by peripartum changes in prolactin and glucocorticoids. Further, we envision that differentiation-associated changes in mammary clock mediate the increase in metabolic output of the gland during lactation ([@B123]).

Milk synthesis and composition shows circadian variation in lactating women ([@B24]). Approximately, seven percent of the genes expressed in the lactating breast show circadian oscillation; many of these genes regulate cell growth and differentiation as well as metabolic pathways ([@B125]). Offspring of homozygous female *Clock-Δ19* mutant mice fail to thrive suggesting that the mutation affects the dam's ability to support milk production during lactation. Our studies of *ClockΔ19 mice* revealed poorer mammary development and evidence for delayed or failed lactogenesis II, with *in vitro* studies demonstrating a role for *Clock* in regulating mammary epithelial growth and differentiation (unpublished data). Miller et al. have evidence to suggest that prolactin release is altered in *ClockΔ19 mice* ([@B126]). Thus, both systemic and mammary-specific alterations likely account for negative impact of *ClockΔ19* mutation on lactation. The photoperiod effect on ruminant milk production ([@B127]) and our studies with cattle showing circadian disruption significantly decreases milk production ([@B46]), also support a role for the circadian timing system in mediating systemic metabolism and mammary metabolic output during lactation.

Consequences of Chronodisruption on Ability of Mother to Support Offspring {#S9}
==========================================================================

Several rodent studies have been designed to determine if circadian disruption impacts pregnancy outcome. These studies found that exposing mice immediately after confirmed mating to continuous shifts in the light-dark cycle (a chronic jet-lag model) resulted in a significant decrease in the number of full-term pregnancies ([@B128]). Rat dams exposed to chronic jet-lag throughout gestation gained 70% less weight during the first week of pregnancy than those housed in control conditions. In late pregnancy (gestation day 20), chronic jet-lag exposure profoundly disrupted timing of corticosterone, leptin, glucose, insulin, free fatty acids, triglycerides, and cholesterol concentrations in these dams. Further, expression of gluconeogenic and circadian clock genes in maternal and fetal liver was arrhythmic relative to controls ([@B129]). Offspring of rat dams exposed to a chronic jet-lag paradigm from the first day of pregnancy to lactation day 10 developed metabolic problems such as obesity, hyperleptinemia, and glucose tolerance/insulin insensitivity when they reached maturity ([@B130]). These studies demonstrate that exposure to chronic circadian disruption during pregnancy impacts the normal maternal metabolic-hormonal adaptations to this physiological state. Further, these perturbations may contribute to the programing of poor metabolic homeostasis in adult offspring.

In humans, a polymorphism in the circadian clock-gene BMAL1 was shown to be associated with increased risk of miscarriages ([@B131]). Studies of shift workers found night and rotating shift work during pregnancy increased the risk of pre-term birth, low birth weight, and miscarriage ([@B132], [@B133]). For example, a retrospective study of a large cohort in women (National Birth Cohort in Denmark) reported a fixed night work schedule increases risk of post-term birth (odds ratio, 1.35; 95% CI, 1.01--1.79). Fixed evening work had a higher risk of full-term low birth weight (odds ratio, 1.80; 95% CI, 1.10--2.94); and shift work as a group showed a slight excess of small-for-gestational-age babies (odds ratio, 1.09; 95% CI, 1.00--1.18) ([@B134]). A population-based prospective cohort study conducted in Sri Lanka found risk factors for small-for-gestational-age were shift work and exposure to physical and chemical hazards during second and third trimesters (odds ratio, 4.20; 95% CI, 1.10--16.0), as well as sleeping ≤8 h during second or third trimesters (odds ratio, 2.23; 95% CI, 1.08--4.59) ([@B135]).

A prospective cohort study of approximately 1,200 healthy pregnant women was used to evaluate the influence of maternal self-reported sleep duration during early pregnancy on blood pressure levels and risk of hypertensive disorders of pregnancy. Investigators found that the mean third trimester systolic blood pressure was higher for women reporting ≤6 and 7--8 h sleep compared with women reporting 9 h of sleep, with odds ratio for pre-eclampsia in very short (\<5 h) sleepers being 9.52 (95% CI, 1.83--49.40) ([@B136]). Sleep disturbances in early pregnancy are also associated with higher risk for development of hyperglycemia ([@B137]). Moreover, gestational diabetes mellitus risk was increased among women sleeping \<4 h compared with those sleeping 9 h per night during early pregnancy with relative risk for overweight women threefold higher ([@B138]). Snoring, which is associated with sleep disturbances, was associated with a 1.86-fold (95% CI, 0.88--3.94) increased risk of gestational diabetes, with the risk being 6.9-fold (95% CI, 2.87--16.6) higher in overweight women who snored compared with lean women ([@B138]). Hyperleptinemia is also an important clinical risk factor for adverse pregnancy outcomes such as pre-eclampsia and gestational diabetes mellitus ([@B139]--[@B141]). A cross-sectional study of 830 pregnant women found that shorter sleep (≤5 h) and longer sleep (≥9 h) were associated with elevated leptin among overweight or obese women ([@B142]).

Researchers have also linked abnormalities in circadian rhythms with development of mood disorders such as bipolar disorder, major depression, and seasonal affective disorder ([@B143], [@B144]). Individuals with major depression exhibit blunted or abnormal circadian rhythms in body temperature, plasma cortisol, norepinephrine, thyroid stimulating hormone, blood pressure, pulse, and melatonin ([@B143]). Studies of depressed pregnant women found significantly lower levels and phased-advanced melatonin secretion in pregnant women with personal and family histories of depression relative to women without history of depression ([@B110]). Further, in healthy women, plasma melatonin levels became increasingly elevated as pregnancy progressed but this increase did not occur in depressed women ([@B110]). Thus, it is interesting to speculate whether mothers with depression are at an increased risk for shorter breastfeeding duration and increased breastfeeding difficulties ([@B145]), in part, through physiological disruption of the circadian timing system, which in turn impacts her milk production (Figure [2](#F2){ref-type="fig"}).

![**Proposed relationships among metabolic-hormonal-circadian clock changes needed to initiate lactogenesis II during the periparturient period, and how related risk factors interfere with initiation**. Arrows indicate inductive relationship. "T" indicates an inhibitory relationship. Question marks indicate areas needing further research to support proposed relationship/mechanism.](fnut-02-00004-g002){#F2}

The association of maternal obesity with DLII appears to have a physiological basis related to alterations in hormones and metabolic adaptations needed to initiate copious milk production (Figure [2](#F2){ref-type="fig"}). In rodent models of obesity, the normal hormonal response to the periparturient period is altered, with a lower rise in prolactin and insulin levels during the transition from pregnancy to lactation and significantly higher corticosterone levels ([@B146]--[@B148]). In obese humans, basal levels of cortisol are also higher with an attenuation of the circadian rhythm ([@B68]) and a lengthening of rhythm period ([@B54]). Circadian rhythms of plasma cortisol are believed to be a primary signal for synchronization of peripheral clocks ([@B149]). Glucocorticoids also regulate milk synthesis ([@B150]). However, antenatal treatment with glucocorticoids delays secretory activation in ewes ([@B151]), and treatment of animals with supra-physiological of glucocorticoids depresses milk production in an established lactation ([@B150]). Thus, the delay in onset of lactogenesis II experienced by obese women may be due to alterations in coordinated changes and interactions among circadian timing system, endocrine milieu, and metabolism needed to initiate copious milk secretion (Figure [2](#F2){ref-type="fig"}).

Conclusion and Potential Interventions {#S10}
======================================

Although there is a paucity of information available to understand the role of the circadian timing system in mediating metabolic and hormonal adaptations to pregnancy and lactation, there is strong evidence that clocks play a role in regulating metabolic and hormonal homeostasis in animals. The circadian system functions to prepare physiological systems and behavioral activity for anticipated changes in the environment (e.g., day--night cycle). In addition, the circadian system also prepares for anticipated changes in physiological--reproductive state (e.g., seasonal fertility in some species). Chronic disruption of the circadian timing system has negative impacts on fertility and fecundity in females. Fertility and fecundity depend on precise hormonal timing and adequate metabolic adaptions to support the extra energy investment of reproduction ([@B92], [@B152]). Similarly, the initiation of lactogenesis II, requires timing coordinated changes in hormones and metabolism to initiate copious milk production in the early post-partum. Thus, we hypothesize that chronic disruption of the maternal circadian timing system during pregnancy and peripartum alters hormones and metabolic adaptations resulting in DLII (Figure [2](#F2){ref-type="fig"}).

Human lactation is a complex phenomenon and the initiation and duration of breastfeeding is influenced by many demographic, physical, social, and psychological variables. Interventions developed to increase the rates of successful breastfeeding target management strategies to ensure adequate milk supply ([@B153]--[@B155]). Although there is evidence to suggest that the circadian system plays a significant role in lactation and maternal behavior, current breastfeeding interventions do not encompass management strategies and education that take into account circadian disruptions. Depressive mood, light, activity, and eating at night (e.g., night-shift work and night-eating syndrome), excessive weight, and sleep disturbances are well characterized chronodisruptors. These chronodisruptors have also been associated with hormonal and metabolic alterations during pregnancy and inadequate breastfeeding outcomes.

Therefore, we propose the need to test interventions aimed at maintaining circadian alignment (e.g., limiting exposure to chronodisruption) during three stages that impact the ability of the mother to initiate and maintain lactogenesis: (1) during pregnancy; (2) in the hospital; and (3) after post-partum discharge from the hospital. Interventions during pregnancy may include, raising mothers' awareness of their sleep, eating and exercise patterns through diaries and self-monitoring, as well and educating mothers about sleep hygiene and consequences of sleep deprivation and interrupted sleep cycle and exposure to light at night.

Good sleep hygiene, together with circadian alignment of food intake, a regular meal frequency, as well as attention for protein intake or diets, may contribute to cure sleep abnormalities and overweight/obesity ([@B47]). Circadian alignment diminishes the urge to overeat, normalizes substrate oxidation, stress, and insulin and glucose metabolism. In addition, circadian alignment impacts leptin concentrations, lipid metabolism, blood pressure, appetite, energy expenditure, and substrate oxidation, and normalizes the experience of food reward ([@B47]). For example, a clinical trial investigated whether sleep extension under real-life conditions is a feasible intervention in 16 healthy non-obese adults who were chronically sleep restricted ([@B156]). The intervention was 2 weeks of habitual time in bed, followed by 6 weeks during which participants were instructed to increase their time in bed by 1 h per day. Continuous actigraphy monitoring and daily sleep logs during the entire study showed that sleep time during weekdays increased (mean actigraphic data: 44 ± 34 min, *P* \< 0.0001; polysomnographic data: 49 ± 68 min, *P* = 0.014), without any significant change during weekends. Changes from habitual time in bed to the end of the intervention in total sleep time correlated with changes in glucose and insulin levels, as well as with indices in insulin sensitivity.

In the hospital, interventions may include implementing light--dark cycles and/or light filters that help to maintain circadian alignment; educating families about the importance of limited visiting hours and number of visitors; and implementing Baby Friendly Hospital Initiative ([@B157]) to include quiet time and light-dark cycles. Discharge interventions may include providing education about sleep hygiene, diet, and activities important to maintain circadian alignment.

Exposure to lighting environments that more closely align to the Earth's natural light--dark cycles may prove to limit metabolic-hormonal disturbances during pregnancy and promote normal metabolic-hormonal adaptations during the peripartum needed to initiate lactation. An example of the recognition that hospital lighting environment impacts physiology, health, and development, comes from studies of infants in Neonatal Intensive Care Units (NICU) \[for review, see Ref. ([@B158])\]. Providing a light--dark cycle in the NICU increased sleeping time in infants, decreased the time spent feeding, and increased weight gain resulting in earlier hospital discharge relative to infants exposed to constant lighting typical of some hospital nurseries ([@B159], [@B160]). In addition, exposure to a light--dark cycle promoted heart rate stability, improved oxygen saturation, establishment of daily melatonin rhythms, and a better tolerance to milk ([@B160]). These studies demonstrate that exposure to a light--dark cycle immediately after birth promotes beneficial effects on the development of infants, and thus support the need for research on the impact of hospital lighting environment on maternal physiology and maternal-offspring interactions in the peripartum that affect breastfeeding outcomes.

Recent studies using animal and clinical models have demonstrated that filtering short wavelengths (below 480 nm) for nocturnal lighting can attenuate alterations in hormone secretion (melatonin and glucocorticoids), and in central and peripheral clock-gene expression induced by nighttime light exposure ([@B161]). In humans, use of optical filters led to an improvement in mood and cognitive performance under controlled laboratory conditions as well as during field-based shiftwork studies. For example, studies found that use of optical filters during shift work increased sleep duration and quality on nights immediately following night shifts ([@B161]). Thus, a method to improve or prevent many of the health problems associated with circadian misalignment, including timing to onset of lactogenesis II may be to incorporate optical filters into glasses or as coverings for light bulbs in work places and hospitals for procedures that require night time exposure to light ([@B161]).

If these proposed interventions prove to mitigate the development of metabolic and hormonal imbalances that increase the risk of DLII, the rates of adequate breastfeeding may increase. Importantly, since many of the external factors that disrupt circadian clocks are modifiable by changes in lifestyle or external environment, the interventions we suggest are minimally invasive and thus are readily implementable during pregnancy and peripartum.
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